Zimmer Biomet Holdings, Inc. ZBH
91.04
1.35
1.51%
as of 25 Sep
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Zimmer Biomet Holdings, Inc. (ZBH) P/E ratio
As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/E ratio of 22.0×. Over the past ten years it has ranged from 0.0× (March 2021) to 708× (September 2020); the current reading is higher than 27% of that period. That is in line with the Medical Devices industry median of 22.2× and in line with the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 25.2× | 6.11% |
| FY2024 | 23.7× | (3.99%) |
| FY2023 | 24.7× | (78.63%) |
| FY2022 | 116× | 81.06% |
| FY2021 | 63.9× | — |
| FY2020 | 0.0× | — |
| FY2019 | 26.4× | — |
| FY2018 | 0.0× | — |
| FY2017 | 13.2× | (80.34%) |
| FY2016 | 67.3× | (38.54%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 20.8× | (10.78%) |
| Mar 2026 | 23.4× | (7.24%) |
| Dec 2025 | 25.2× | 3.82% |
| Sep 2025 | 24.3× | 9.59% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 708×
Ten-year median
28.1×
Current reading's percentile
27
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| GMED Globus Medical, Inc. compare | 18.8× |
| ZBH Zimmer Biomet Holdings, Inc. | 22.0× |
| STE STERIS plc compare | 25.4× |
| SNN Smith & Nephew SNATS, Inc. compare | 32.8× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 43.8× |
| BIO Bio-Rad Laboratories, Inc. compare | 45.7× |
| PEN Penumbra, Inc. compare | 78.0× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement